ATLASBright Minds Biosciences (DRUG) earnings date: Dec 22, 2026
Bright Minds Biosciences (DRUG) reports earnings for the quarter ended Sep 30, 2026 on Tue, Dec 22, 2026, after the close. Analysts expect EPS of -$1.07.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on DRUG
| Last price | $25.70 (-53.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.0% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Bright Minds Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Bright Minds Biosciences reports on Dec 22, 2026. One email the day before, with ATLAS’s read on Bright Minds Biosciences. You can switch it off at any time.
Alert me before DRUG reportsFree to start. Creating an account takes under a minute.
Notify me when Bright Minds Biosciences reports
Track DRUG free Add Bright Minds Biosciences to a free ATLAS watchlist and see its next report date in one place.
DRUG earnings at a glance
| Next report (confirmed) | Tue, Dec 22, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.07 |
| Last report | Aug 14, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +31.2% |
| Average move around a report | ±4.8% (last 4) |
| Sector | Healthcare · Biotechnology |
Bright Minds Biosciences earnings history: last 4 reports
Bright Minds Biosciences last reported on Aug 14, 2026: EPS of -$0.24 against an estimate of -$1.64 (+85.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$1.64 | -$0.24 | +85.4% | Beat | +1.9% |
| May 19, 2026 | -$1.26 | -$1.09 | +13.5% | Beat | +10.4% |
| Feb 12, 2026 | -$1.18 | -$0.97 | +17.8% | Beat | 0.0% |
| Jan 27, 2026 | $2.20 | $2.38 | +8.2% | Beat | -6.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for DRUG
See the fair value, the probability range and the earnings history of Bright Minds Biosciences on its ATLAS page.
Bright Minds Biosciences (DRUG) stock analysisPlans from €3.99 a month.
Bright Minds Biosciences earnings: frequently asked questions
When does Bright Minds Biosciences (DRUG) report earnings?
Bright Minds Biosciences is scheduled to report on Tuesday, December 22, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for DRUG?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.07 per share (USD). Estimates can change before the report.
How often does DRUG beat earnings estimates?
Of its last 4 reports with a recorded result, Bright Minds Biosciences beat the EPS estimate 4 times; the average surprise was +31.2%. Past results do not predict the next one.
How much does DRUG move around earnings?
Over its last 4 reports the stock moved an average of 4.8% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Bright Minds Biosciences beat earnings estimates last quarter?
Bright Minds Biosciences last reported on Aug 14, 2026: EPS of -$0.24 against an estimate of -$1.64 (+85.4% surprise), a beat.
How much does DRUG usually move in a day?
On a normal trading day the ATLAS model puts DRUG’s one-day range at about ±4.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Dec 22, 2026
Educational information, not investment advice. Disclaimer